AKYNZEO

Formula & Concentration

AKYNZEO – fosnetupitant 235 mg-palonosetron 0.25 mg/20 mL intravenous solution

Manufacturer

Helsinn Therapeutics US, Inc.

Indications

Prevention of chemotherapy-induced nausea and vomiting

Product Options

Package Size

NDC #

Presentation

235 – 0.25 mg

69639-0106-01

Vial

300 – 0.5 mg

69639-0101-01

Capsule

Shelf Life and Storage

Controlled Room Temp (20-25°C)